MktsMarkets

Myriad Genetics, Inc.
NASDAQ: MYGNKey statistics
MYGN News
Stories mentioning MYGN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 200,400 | 209,800 | 205,700 | 213,100 | 195,900 | 210,600 | 213,300 | 211,500 |
| Cost of Goods Sold | 62,800 | 63,000 | 61,900 | 61,300 | 61,700 | 59,700 | 63,500 | 64,400 |
| Gross Profit | 137,600 | 146,800 | 143,800 | 151,800 | 134,200 | 150,900 | 149,800 | 147,100 |
| Operating Expenses | ||||||||
| Research & Development | 27,100 | 25,500 | 28,200 | 25,600 | 27,500 | 32,900 | 28,500 | 27,100 |
| Sales General & Admin | 139,100 | 144,900 | ||||||
| Total Operating Expenses | 168,300 | 152,500 | 167,100 | 481,000 | 163,200 | 190,000 | 169,800 | 183,600 |
| Operating Income (Loss) | (30,700) | (5,700) | (23,300) | (329,200) | (29,000) | (39,100) | (20,000) | (36,500) |
| Interest Income | 700.00 | 800.00 | 500.00 | 200.00 | 300.00 | 300.00 | 400.00 | 400.00 |
| Interest Expense | ||||||||
| Other Expense | 0.00 | 400.00 | 400.00 | (100.00) | 100.00 | 300.00 | (800.00) | (300.00) |
| Pretax Income | (34,100) | (8,900) | (26,200) | (330,600) | (29,400) | (39,200) | (21,200) | (37,200) |
| Tax Provision | 0.00 | (1,000) | 1,200 | (100.00) | (29,300) | 3,300 | 900.00 | (500.00) |
| Net Income (Loss) | (34,100) | (7,900) | (27,400) | (330,500) | (100.00) | (42,500) | (22,100) | (36,700) |
| Earnings Per Share (Basic) | (0.36) | (0.09) | (0.29) | (3.57) | 0.00 | (0.47) | (0.24) | (0.41) |
| Earnings Per Share (Diluted) | (0.36) | (0.09) | (0.29) | (3.57) | 0.00 | (0.47) | (0.24) | (0.41) |
| Weighted Average Shares Outstanding (Basic) | 93,700 | 92,600 | 93,100 | 92,500 | 91,400 | 90,600 | 90,900 | 90,600 |
| Weighted Average Shares Outstanding (Diluted) | 93,700 | 92,600 | 93,100 | 92,500 | 91,400 | 90,600 | 90,900 | 90,600 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MYGN
Myriad Genetics, Inc. (NASDAQ: MYGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol MYGN. It last traded at $5.53 (Nov 18, 2026, 4:00 PM ET), down 0.2% on the day. That gives Myriad Genetics a market capitalisation of $531.4M.
Over the past 52 weeks MYGN has traded between $2.74 and $8.09.
Revenue for the quarter ended Mar 31, 2026 was $200.4M; a net loss of $34.1M. Revenue was up 2.3% from $195.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $200.4M | -$34.1M | -17.0% |
| Dec 31, 2025 | $209.8M | -$7.9M | -3.8% |
| Sep 30, 2025 | $205.7M | -$27.4M | -13.3% |
| Jun 30, 2025 | $213.1M | -$330.5M | -155.1% |
From Myriad Genetics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…